CMET-25. PROGRESSION-FREE SURVIVAL (PFS) AND SITE OF FIRST PROGRESSION IN HER2+ METASTATIC BREAST CANCER PATIENTS WITH OR WITHOUT BRAIN METASTASES: A POOLED ANALYSIS OF TUCATINIB PHASE I STUDIES
Autor: | Marc C. Chamberlain, Alison Conlin, Erika Hamilton, Stacy L. Moulder, Todd Gray, Cristiano Ferrario, Ian E. Krop, Virginia F. Borges |
---|---|
Rok vydání: | 2017 |
Předmět: |
Oncology
Cancer Research medicine.medical_specialty medicine.diagnostic_test business.industry Disease progression Magnetic resonance imaging medicine.disease Metastatic breast cancer Capecitabine Abstracts Text mining Pooled analysis Trastuzumab Internal medicine medicine Neurology (clinical) Progression-free survival business medicine.drug |
Zdroj: | Neuro-Oncology. 19:vi44-vi44 |
ISSN: | 1523-5866 1522-8517 |
Databáze: | OpenAIRE |
Externí odkaz: |